- LDS
- /Medical Tests
- /HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma
Diseases (1)Access to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
OverviewAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
Clinical UtilityAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
InterpretationAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
Reference RangesAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
MethodologyAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
Turnaround TimeAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
CPTAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
LOINCAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
ICD10Access to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
Additional ICD10Access to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.
ReferencesAccess to HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug Resistance, Plasma is restricted.